# Global Brain Corporation's Biotech Investments: 14 Startups in Its Portfolio (2026)

> The 14 Biotech startups Global Brain Corporation has backed, by stage: $661M raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/global-brain-corporation-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Stage not reported

6

- [*H* Healx](https://millionrounds.com/company/healx)
- [Metaphore Biotechnologies](https://millionrounds.com/company/metaphore-biotechnologies)
- [ChromaCode](https://millionrounds.com/company/chromacode)
- [MedRhythms](https://millionrounds.com/company/medrhythms)
- [EditForce](https://millionrounds.com/company/editforce)
- [Visolis](https://millionrounds.com/company/visolis)

## Series A

3

- [GC Therapeutics](https://millionrounds.com/company/gc-therapeutics)
- [Switch Therapeutics](https://millionrounds.com/company/switch-therapeutics)
- [Shoulder Innovations](https://millionrounds.com/company/shoulder-innovations)

## Series C and later

3

- [bit.bio](https://millionrounds.com/company/bit-bio)
- [ThinkCyte](https://millionrounds.com/company/thinkcyte)
- [Siolta Therapeutics](https://millionrounds.com/company/siolta-therapeutics)

## Series B

2

- [Rege Nephro](https://millionrounds.com/company/rege-nephro)
- [*A* Awair](https://millionrounds.com/company/awair)

## Segment by segment

### Stage not reported

6 startups · $180M raised

- [*H* **Healx**](https://millionrounds.com/company/healx) United Kingdom $66M
- [**Metaphore Biotechnologies**](https://millionrounds.com/company/metaphore-biotechnologies) Metaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering. United States $50M
- [**ChromaCode**](https://millionrounds.com/company/chromacode) ChromaCode is a molecular diagnostics company focusing on bioinformatics. United States $44M
- [**MedRhythms**](https://millionrounds.com/company/medrhythms) Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking. United States $9.6M
- [**EditForce**](https://millionrounds.com/company/editforce) 九州大学発のRNA編集技術にもとづく創薬開発をおこなう、エディットフォース株式会社。独自のRNA編集技術を活用し、医療、産業、農業などの様々な分野において新たな世界標準をつくります。 Japan $7.3M
- [**Visolis**](https://millionrounds.com/company/visolis) Visolis, a bioengineering company, develops carbon-negative and sustainable chemicals. United States $2.9M

### Series A

3 startups · $166M raised

- [**GC Therapeutics**](https://millionrounds.com/company/gc-therapeutics) GC Therapeutics (GCTx) is a biopharmaceutical and biotechnology company based in Cambridge, Massachusetts, founded in 2019. United States $65M
- [**Switch Therapeutics**](https://millionrounds.com/company/switch-therapeutics) Switch Therapeutics is a preclinical-stage biotechnology company founded in 2020, focused on developing innovative RNA interferenc United States $52M
- [**Shoulder Innovations**](https://millionrounds.com/company/shoulder-innovations) Shoulder Innovations is a medical device company that develops inset glenoid fixation technology. United States $49M

### Series C and later

3 startups · $290M raised

- [**bit.bio**](https://millionrounds.com/company/bit-bio) bit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom. United Kingdom $264M
- [**ThinkCyte**](https://millionrounds.com/company/thinkcyte) ThinkCyte is a biotechnology company founded in 2016, specializing in AI-based cell analysis, characterization, and sorting technologies. Japan $15M
- [**Siolta Therapeutics**](https://millionrounds.com/company/siolta-therapeutics) Siolta Therapeutics, Inc. United States $12M

### Series B

2 startups · $25M raised

- [**Rege Nephro**](https://millionrounds.com/company/rege-nephro) Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics. Japan $15M
- [*A* **Awair**](https://millionrounds.com/company/awair) United States $10M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Global Brain Corporation as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **Global Brain Corporation's AI portfolio** 39 startups · $1.4B](https://millionrounds.com/portfolio-maps/global-brain-corporation-ai-portfolio)[Sector portfolio **Global Brain Corporation's Consumer Apps portfolio** 14 startups · $316M](https://millionrounds.com/portfolio-maps/global-brain-corporation-consumer-apps-portfolio)[Sector portfolio **Global Brain Corporation's Fintech portfolio** 12 startups · $232M](https://millionrounds.com/portfolio-maps/global-brain-corporation-fintech-portfolio)[Portfolio map **Global Brain Corporation portfolio map** 147 startups · $5.9B](https://millionrounds.com/portfolio-maps/global-brain-corporation-portfolio-map)[Co-investors **Who invests with Global Brain Corporation** 144 co-investors](https://millionrounds.com/portfolio-maps/global-brain-corporation-co-investors)[Investments abroad **Global Brain Corporation's investments in the United States** 44 startups · $1.5B](https://millionrounds.com/portfolio-maps/global-brain-corporation-investments-united-states)

## Raising from investors like Global Brain Corporation?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
